These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients]. Zabolotskikh IB; Sin'kov SV; Klevko VA Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909 [No Abstract] [Full Text] [Related]
4. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Hatef DA; Kenkel JM; Nguyen MQ; Farkas JP; Abtahi F; Rohrich RJ; Brown SA Plast Reconstr Surg; 2008 Jul; 122(1):269-279. PubMed ID: 18594417 [TBL] [Abstract][Full Text] [Related]
6. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial. Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436 [TBL] [Abstract][Full Text] [Related]
7. [Application of clexane in urosepsis: necessity or the issue of fashion]. Usenko LV; Garmish OS; Zabashnyĭ SI; Stadnichuk GN; Ovchinnikova LIu; Biriukov VV Klin Khir; 2001 Jun; (6):54-7. PubMed ID: 11688269 [TBL] [Abstract][Full Text] [Related]
8. [Application of clexane in reconstructive surgery of the aorta arch vessels for the arterial thrombosis prophylaxis]. Mishalov VG; Litvinova NIu; Seliuk VM; Cherniak VA Klin Khir; 2001 Sep; (9):12-4. PubMed ID: 11785391 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA; Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716 [TBL] [Abstract][Full Text] [Related]
10. [Clexane and regional anesthesia. Contraindication or possible combination?]. Zabashnyĭ SI; Garmish OS; Biriukov VV; Stadnichuk GN; Smirnova IaV Klin Khir; 2001; (5):33-5. PubMed ID: 11503332 [TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW; Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756 [TBL] [Abstract][Full Text] [Related]
12. [Prophylaxis of thromboembolic complications in patients, operated on for alimentary-constitutional obesity]. Grubnik VV; Golliak VP; Grubnik AV Klin Khir; 2006 Sep; (9):35-9. PubMed ID: 17269389 [TBL] [Abstract][Full Text] [Related]
13. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Hamad GG; Choban PS Obes Surg; 2005; 15(10):1368-74. PubMed ID: 16354513 [TBL] [Abstract][Full Text] [Related]
14. Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography. Attaran S; Somov P; Awad WI Eur J Cardiothorac Surg; 2010 Jun; 37(6):1384-90. PubMed ID: 20153216 [TBL] [Abstract][Full Text] [Related]
15. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Scholten DJ; Hoedema RM; Scholten SE Obes Surg; 2002 Feb; 12(1):19-24. PubMed ID: 11868291 [TBL] [Abstract][Full Text] [Related]
16. Dabigatran: new drug. Continue to use heparin, a better-known option. Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411 [TBL] [Abstract][Full Text] [Related]
17. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients. Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998 [TBL] [Abstract][Full Text] [Related]
18. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin. Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404 [TBL] [Abstract][Full Text] [Related]
19. [Administration of clexane 4000 U/0.4 ml (40 mg) for preventing venous thromboembolic complications in patients undergoing surgery for malignant tumors. A follow-up study]. Farkas E; Péley G; Mátrai Z; Rényi-Vámos F; Köves I Magy Seb; 2005 Jun; 58(3):197-200. PubMed ID: 16167477 [TBL] [Abstract][Full Text] [Related]
20. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin. Spinal Cord Injury Thromboprophylaxis Investigators J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]